Multiple changes in gene expression in chronic human Achilles tendinopathy

Deborah Ireland (Lead Author), Rebecca Harrall, Valerie Curry, Graham Holloway, Roger Hackney, Brian Hazleman, Graham Riley

Research output: Contribution to journalArticlepeer-review

208 Citations (Scopus)
8 Downloads (Pure)


Atlas™ cDNA cell interaction arrays (CLONTECH) were used to examine degenerate tissue from four patients with Achilles tendon disorders, in order to identify changes in expression of genes important in cell–cell and cell–matrix interactions. The greatest difference between normal (post-mortem) and degenerate tissue samples was in the level of MMP-3 (stromelysin) mRNA, which was down-regulated in all the degenerate samples. Quantitative RT-PCR assay of RNA extracted from paired ‘normal’ and degenerate Achilles tendon tissue samples taken from tendons during surgery mirrored the results of the arrays. Levels of MMP-3 mRNA were lower, whereas levels of type-I and type-III collagen mRNAs were significantly higher, in the degenerate compared to the ‘normal’ samples. Immunoblotting of proteins extracted from the same tendon samples showed that three of four normal tissue samples taken from individuals without apparent tendon disorder had much higher levels of MMP-3 protein than ‘normal’ or degenerate samples from patients with tendinosis. We suggest that MMP-3 may play an important role in the regulation of tendon extracellular matrix degradation and tissue remodelling.
Original languageEnglish
Pages (from-to)159-169
Number of pages11
JournalMatrix Biology
Issue number3
Publication statusPublished - Jun 2001

Cite this